Havens Advisors Llc increased Straight Path Communicatns I (STRP) stake by 9.38% reported in 2017Q4 SEC filing. Havens Advisors Llc acquired 6,000 shares as Straight Path Communicatns I (STRP)’s stock 0.00%. The Havens Advisors Llc holds 70,000 shares with $12.73M value, up from 64,000 last quarter. Straight Path Communicatns I now has $2.34 billion valuation. The stock decreased 1.35% or $2.5 during the last trading session, reaching $183.37. About 1.83 million shares traded or 592.83% up from the average. Straight Path Communications Inc. (NYSEMKT:STRP) has 0.00% since April 8, 2017 and is . It has underperformed by 11.55% the S&P500.
Segall Bryant & Hamill Llc decreased Johnson & Johnson Co (JNJ) stake by 2.71% reported in 2017Q4 SEC filing. Segall Bryant & Hamill Llc sold 12,348 shares as Johnson & Johnson Co (JNJ)’s stock declined 9.21%. The Segall Bryant & Hamill Llc holds 443,171 shares with $61.92 million value, down from 455,519 last quarter. Johnson & Johnson Co now has $343.65 billion valuation. The stock decreased 2.00% or $2.61 during the last trading session, reaching $128.1. About 6.40 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 8, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.
Since October 13, 2017, it had 0 buys, and 9 insider sales for $12.57 million activity. 3,000 shares valued at $544,395 were sold by ZEIDMAN FRED S on Friday, October 13. 9,723 shares were sold by PI ZHOUYUE, worth $1.77M. 300 shares were sold by RAND JONATHAN, worth $54,474. BREAU DAVID L also sold $724,780 worth of Straight Path Communications Inc. (NYSEAMERICAN:STRP) shares. TODD K CHRIS had sold 7,700 shares worth $1.40 million. WELD WILLIAM F sold $1.45M worth of stock or 8,000 shares.
Investors sentiment decreased to 1.28 in Q4 2017. Its down 0.45, from 1.73 in 2017Q3. It dived, as 11 investors sold STRP shares while 35 reduced holdings. 16 funds opened positions while 43 raised stakes. 6.96 million shares or 4.73% more from 6.64 million shares in 2017Q3 were reported. 340,483 are owned by Magnetar Fin Limited Liability Company. Bluefin Trading Lc holds 0.88% or 79,418 shares. Principal Fin Gp invested 0% of its portfolio in Straight Path Communications Inc. (NYSEAMERICAN:STRP). Wolverine Asset Mngmt Ltd Com stated it has 6,100 shares. Carlson Lp invested 0.47% in Straight Path Communications Inc. (NYSEAMERICAN:STRP). Metropolitan Life Insur, a New York-based fund reported 3,129 shares. Prudential Fincl accumulated 1,174 shares. 25,000 were accumulated by Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta. Dimensional Fund Advisors LP reported 82,893 shares. Great West Life Assurance Can has 715 shares. Asset Incorporated holds 1.23% or 50,000 shares in its portfolio. Halcyon Partners Ltd Partnership invested in 125,364 shares. 1,850 are owned by Proshare Advsrs. California State Teachers Retirement Sys stated it has 0.01% in Straight Path Communications Inc. (NYSEAMERICAN:STRP). Marshall Wace Limited Liability Partnership invested in 0.26% or 34,252 shares.
Since February 15, 2018, it had 0 insider purchases, and 1 insider sale for $20.17 million activity. Stoffels Paulus had sold 155,342 shares worth $20.17 million on Thursday, February 15.
Segall Bryant & Hamill Llc increased Silgan Holdings Inc (NASDAQ:SLGN) stake by 19,337 shares to 167,411 valued at $4.92M in 2017Q4. It also upped Graco Inc. (NYSE:GGG) stake by 119,620 shares and now owns 179,876 shares. Integra Lifesciences Hldgs Cp (NASDAQ:IART) was raised too.
Investors sentiment increased to 0.87 in 2017 Q4. Its up 0.04, from 0.83 in 2017Q3. It increased, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. Skba Mgmt Ltd Liability holds 0.07% or 3,700 shares in its portfolio. Williams Jones And Assocs Llc stated it has 663,615 shares or 2.11% of all its holdings. Monroe Retail Bank Tru Mi accumulated 10,724 shares. Mengis Management has invested 2.45% of its portfolio in Johnson & Johnson (NYSE:JNJ). Douglass Winthrop Limited Liability reported 199,354 shares or 1.52% of all its holdings. Pictet North America Advisors Sa owns 4,386 shares or 0.09% of their US portfolio. Sfe Investment Counsel has invested 1.26% in Johnson & Johnson (NYSE:JNJ). Sterling Invest Mgmt holds 2,410 shares or 0.36% of its portfolio. Burke & Herbert Savings Bank accumulated 45,597 shares. American International Grp owns 1.03M shares for 0.47% of their portfolio. Baldwin Investment Management Ltd Limited Liability Company invested 0.33% in Johnson & Johnson (NYSE:JNJ). D Scott Neal Incorporated holds 1,277 shares. Credit Suisse Ag holds 0.62% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 4.90M shares. Guardian Investment Management holds 27,609 shares or 4.07% of its portfolio. Moon Cap Management Ltd Llc owns 6,460 shares or 0.92% of their US portfolio.
Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson has $170.0 highest and $90 lowest target. $137.17’s average target is 7.08% above currents $128.1 stock price. Johnson & Johnson had 92 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was upgraded by JP Morgan on Monday, May 15 to “Overweight”. The firm has “Buy” rating given on Tuesday, June 13 by Cowen & Co. The firm has “Sell” rating given on Friday, May 20 by Standpoint Research. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Argus Research on Wednesday, April 20. The company was maintained on Monday, July 10 by RBC Capital Markets. On Wednesday, January 25 the stock rating was maintained by RBC Capital Markets with “Outperform”. The rating was maintained by RBC Capital Markets with “Buy” on Friday, September 22. The rating was maintained by BMO Capital Markets on Thursday, August 31 with “Buy”. The stock has “Hold” rating by Stifel Nicolaus on Tuesday, July 18. The firm has “Buy” rating by Cowen & Co given on Friday, October 6.
Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on April, 17. They expect $2.01 earnings per share, up 9.84% or $0.18 from last year’s $1.83 per share. JNJ’s profit will be $5.39B for 15.93 P/E if the $2.01 EPS becomes a reality. After $1.74 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts 15.52% EPS growth.